Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on Owlstone Medical — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA
Contract Type
agreement
CambridgeBiotechnologyHealth CareDescription
Owlstone Medical has entered into a five-year Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL) to develop methods for the confident identification of individual chemicals in the complex mixture of breath. The goal of the collaboration is to develop Regulatory Science Tools (RSTs) for the identification of Volatile Organic Compounds (VOCs) in complex mixtures.
Related People
Sign in to view contact details